First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients

NCT05964361 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Pancreas Cancer
Ovarian Cancer
Liver Cancer

Interventions

BIOLOGICAL: IL15-transpresenting WT1-targeted Dendritic Cell Vaccine

Sponsor

University Hospital, Antwerp

Collaborators

[object Object]
[object Object]